Doxorubicin Cardiotoxicity and the Control of Iron Metabolism: Quinone-Dependent and Independent Mechanisms
Authors:
- Giorgio MinottiGMGiorgio Minotti
- Stefania RecalcatiSRStefania Recalcati
- Pierantonio MennaPierantonio Menna
- Emanuela SalvatorelliESEmanuela Salvatorelli
- Gianfranca CornaGCGianfranca Corna
- Gaetano CairoGaetano Cairo
- 1 January 2004
- book chapter
- Published by Elsevier
- Vol. 378, 340-361
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxideBiochemical Journal, 2002
- Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogueBritish Journal of Pharmacology, 2001
- Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinOncogene, 2001
- Human Cytoplasmic Aconitase (Iron Regulatory Protein 1) Is Converted into Its [3Fe-4S] Form by Hydrogen Peroxide in Vitro but Is Not Activated for Iron-responsive Element BindingJournal of Biological Chemistry, 1999
- Inactivation of Both RNA Binding and Aconitase Activities of Iron Regulatory Protein-1 by Quinone-induced Oxidative StressJournal of Biological Chemistry, 1999
- Iron regulatory proteins 1 and 2BioEssays, 1996
- Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.Journal of Clinical Investigation, 1996
- Differential Modulation of the RNA-binding Proteins IRP-1 and IRP-2 in Response to IronJournal of Biological Chemistry, 1995
- ATP-dependent Regulation of Sodium-Calcium Exchange in Chinese Hamster Ovary Cells Transfected with the Bovine Cardiac Sodium-Calcium ExchangerJournal of Biological Chemistry, 1995
- Comparative metabolism and pharmacokinetics of doxorubicin and 4′-epidoxorubicin in plasma, heart and tumor of tumor-bearing miceCancer Chemotherapy and Pharmacology, 1990